# Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis

> **NCT04041856** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Farabi Eye Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Adenoviral Keratoconjunctivitis

## Interventions

- **DRUG:** Povidone Ophthalmic

## Key facts

- **NCT ID:** NCT04041856
- **Lead sponsor:** Farabi Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-23
- **Primary completion:** 2019-10-22
- **Final completion:** 2019-11-22
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04041856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04041856, "Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04041856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*